|
Richard Eastell MD, FRCP (London, Edinburgh, Ireland), FRCPath, FMedSci (born 12 February 1953) is a British medical doctor and Professor of Bone Metabolism at the University of Sheffield.〔(Academic Unit of Bone Metabolism )〕 He was born in Shipley (West Yorkshire) and attended the Salt Grammar School, later graduating from the University of Edinburgh in 1977 with a MB ChB and in 1984 with a MD and achieved prominence as an expert in osteoporosis. ==Professional life== Eastell received a clinical fellowship from the Medical Research Council to study osteoporosis at the University of Edinburgh in 1978. He furthered his clinical research training by working at the Mayo Clinic under the supervision of Dr B L Riggs where he worked for five years. Eastell developed a number of new approaches for studying osteoporosis while at the Mayo Clinic including the use of stable (non-radioactive) isotopes to measure the absorption of calcium from food, the use an infusion technique to measure the production of the active form of vitamin D, the measurement of bone density at the site in the wrist where fractures commonly occur (the ultradistal radius) and a height ratio approach to identifying vertebral fractures on radiographs of the spine. He began his training in endocrinology and diabetes at the Western General Hospital in Edinburgh in 1980 and continued it at Northwick Park Hospital in Harrow in 1982 and at the Mayo Clinic in 1987.〔(University of Sheffield staff page for Eastell )〕 He joined the Department of Human Metabolism and Clinical Biochemistry at the University of Sheffield in 1989 as a Senior Research Fellow and Honorary Consultant. He set up a metabolic bone service at the Northern General Hospital.〔(Metabolic Bone Centre )〕 He became Professor of Bone Metabolism in 1995 and he received funding from the Arthritis Research Campaign to use biochemical tests of bone turnover to better understand the way in which older men and women develop osteoporosis and propensity to fracture. His studies on the cause, diagnosis, prevention and treatment of osteoporosis have been conducted with the support of many colleagues; he has supervised the study for higher degree of 36 scientists and doctors over the past 20 years.〔 Eastell has been president of the Bone Research Society〔(Bone Research Society Speaker Biographies )〕 and chairman of the board of trustees of the National Osteoporosis Society〔(National Osteoporosis Society AGM Minutes, 2009 )〕 in the UK, and by his presidency of the European Calcified Tissue Society.〔(European Calcified Tissue Society Directors )〕 He has published over 320 articles on metabolic bone diseases.〔(PubMed search for Eastell R )〕 Eastell is currently director of the National Institute for Health Research’s Bone Biomedical Research Unit, based at the Northern General Hospital in Sheffield.〔(The Bone Biomedical Research Unit in Sheffield )〕 He became a NIHR Senior Investigator in 2009.〔(National Institute of Health Research, list of Senior Investigators )〕 Some of his recent contributions have been authorship on key commercially sponsored papers describing new treatments for osteoporosis, such tibolone,〔Cummings SR, et al. The effects of tibolone in older postmenopausal women. N Engl J Med. 2008 Aug 14;359(7):697-708.〕 zoledronic acid,〔Black DM, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007 May 3;356(18):1809-22.〕 denosumab〔Cummings SR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009 Aug 20;361(8):756-65〕 and lasofoxifene〔Cummings SR, et al. Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med. 2010 Feb 25;362(8):686-96.〕 as well as addressing key issues about safety of medications〔Black DM, et al. Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur. N Engl J Med. 2010 Mar 24〕 and provide guidelines to diagnose primary hyperparathyroidism, a common disorder resulting in high levels of blood calcium.〔Eastell R, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009 Feb;94(2):340-50.〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Richard Eastell」の詳細全文を読む スポンサード リンク
|